2 In 1944, Hans Asperger identified a group children have severe social abnormalities and motor disorders but with very high intellectual functioning
Biometals 27 , 13711382 (2014)
464,465 New biomarkers and drug intervention targets to improve the prognosis of DPD hold enormous potential for clinical applications
Landmark trials such as SCALE, STEP, OASIS, SURMOUNT, and ATTAIN have demonstrated the efficacy of liraglutide, oral and injectable semaglutide, and tirzepatide in producing substantial and durable reductions in body weight, thereby redefining pharmacologic approaches to long-term weight-management therapy
L-Glutathione Vitamin c Astaxanthin N-acetyl L-cysteine for skin brightening